☆ 4.7 Meeting Abstract

PHASE I INTERIM STUDY RESULTS OF NOUS-209, AN OFF-THE-SHELF IMMUNOTHERAPY, WITH PEMBROLIZUMAB, FOR THE TREATMENT OF TUMORS WITH A DEFICIENCY IN MISMATCH REPAIR/MICROSATELLITE INSTABILITY (DMMR/MSI)

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Get Full Text
Add to Collection

Journal

JOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume 9, Issue -, Pages A441-A441

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jitc-2021-SITC2021.410

Keywords

-

Categories

Oncology Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.